Rezolve AI
RZLV
2.08
-0.07
-3.26%
Rezolve AI
US · RZLV
#3351 by market cap
2.08
-0.07
-3.26%
Live - 5344 symbols - heartbeat 332s ago
· 2026-10-08 09:20
Pre-market
2.07
-0.50%
After-hours
2.08
0.00%
Overnight
2.09
+0.48%
- Market cap
- 867.09M
- P/E (TTM)i
- -4.33
- P/Bi
- 2.06
- EPSi
- -0.38
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on RZLV?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.04, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +2,224.24% YoY
Margins
- Gross margin
- 65.98%
- Operating margin
- -185.59%
- Net margin
- -216.69%
Key ratios & quality
- Enterprise valuei
- 912.43M
- Altman Z-Scorei
- 0.04
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3.90M | 115.16K | 145.05K | 2.01M | 46.80M |
| Gross profit | 2.16M | -629.88K | 110.26K | 1.82M | 30.88M |
| Selling & admin expenses | 38.97M | 90.98M | 24.72M | 138.71M | 102.43M |
| Research & development | -559.12K | -467.56K | -497.98K | 1.15M | 11.20M |
| Operating profit | -36.70M | -91.71M | -25.51M | -138.52M | -86.86M |
| Pretax profit | -37.75M | -110.67M | -30.67M | -173.21M | -119.14M |
| Tax | -26.76K | 38.77K | 63.41K | 243.74K | -17.73M |
| Net profit | -37.72M | -110.71M | -30.74M | -173.45M | -101.41M |
| Basic EPS | 0 | -1 | 0 | -1 | 0 |
| Diluted EPS | -0.20 | -0.60 | -0.17 | -1.06 | -0.38 |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -- | -- | -- | -- | -- | -- |
| Pretax profit | -- | -- | -- | -- | -- | -- |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -- | -- | -- | -- | -- | -- |
| Basic EPS | -- | -- | -- | -- | -- | -- |
| Diluted EPS | -- | -- | -- | -- | -- | -- |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 5.83M | 1.09M | 321.99K | 14.02M | 174.95M |
| Cash & ST investments | 2.69M | 39.38K | 10.44K | 9.73M | 111.11M |
| Inventory | 355.05K | -- | -- | -- | -- |
| Total assets | 22.37M | 1.65M | 2.54M | 21.17M | 611.73M |
| Total current liabilities | 18.92M | 7.69M | 56.82M | 62.44M | 262.07M |
| Short-term debt | 743.30K | 697.07K | 37.45M | 34.73M | 106.36M |
| Long-term debt | 2.51M | 25.30M | -- | -- | 50.09M |
| Total liabilities | 24,299,911.00 | 34,168,542.00 | 56,821,368.00 | 62,438,636.00 | 364,918,858.00 |
| Total equity | -1.93M | -32.52M | -54.28M | -41.27M | 246.82M |
| Retained earnings | -85.07M | -195.56M | -226.29M | -258.21M | -359.62M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 321.99K | 502.42K | 14.02M | 22.58M | 174.95M | 200.35M |
| Cash & ST investments | 10.44K | 60.30K | 9.73M | 9.86M | 111.11M | 33.15M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.54M | 3.96M | 21.17M | 80.10M | 611.73M | 917.90M |
| Total current liabilities | 56.82M | 22.78M | 62.44M | 93.65M | 262.07M | 405.58M |
| Short-term debt | 37.45M | 1.30M | 34.73M | 34.82M | 106.36M | 127.31M |
| Long-term debt | -- | 44.13M | -- | 121.14K | 50.09M | 30.09M |
| Total liabilities | 56,821,368.00 | 66,909,581.00 | 62,438,636.00 | 94,391,811.00 | 364,918,858.00 | 515,678,000.00 |
| Total equity | -54.28M | -62.95M | -41.27M | -14.29M | 246.82M | 402.22M |
| Retained earnings | -226.29M | -239.13M | -258.21M | -316.06M | -359.62M | -499.10M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | -20.44M | -26.79M | -13.00M | -22.38M | -63.15M |
| Depreciation & amortization | 460.49K | 244.21K | 242.44K | 226.31K | 6.97M |
| Free cash flow | -20.56M | -26.83M | -14.78M | -25.91M | -87.09M |
| Dividends paid | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 603.82K | 2.50M | 7.97M | 19.61M | 251.41M |
| Ending cash balance | 2.69M | 39.38K | 10.44K | 9.73M | 111.11M |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | -- | -- | -- | -- |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | -- | -- | -- | -- | -- | -- |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | -- | -- | -- | -- | -- | -- |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -97.13 |
| ROA %i | -168.59 | -717.16 | -518.03 | -1,546.69 | -32.12 |
| ROIC %i | -- | -- | -- | -- | -43.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | -958.99 | -879.34 | -17,842.63 | -86,291.00 | -247.08 |
| FCF / sales %i | -- | -- | -- | -- | -- |
| Current ratioi | 0.31 | 0.14 | 0.01 | 0.22 | 0.67 |
| Quick ratioi | 0.26 | 0.11 | 0.00 | 0.18 | 0.60 |
| Debt / assetsi | 14.70 | 1,576.76 | 1,476.31 | 164.05 | 25.71 |
| LT debt / equityi | -- | -- | -- | -- | 20.63 |
| Interest coveragei | -124.16 | -27.90 | -5.40 | -15.35 | -32.97 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -19.81 | 640.71 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2023-12 | 2024-06 | 2024-12 | 2025-06 | 2025-12 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -97.13 | -94.37 |
| ROA %i | -518.03 | -664.13 | -1,546.69 | -517.55 | -32.12 | -36.68 |
| ROIC %i | -- | -- | -- | -- | -43.58 | -58.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -17,842.63 | -14,171.88 | -86,291.00 | -3,912.64 | -247.08 | -113.95 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 0.01 | 0.02 | 0.22 | 0.24 | 0.67 | 0.49 |
| Quick ratioi | 0.00 | 0.01 | 0.18 | 0.22 | 0.60 | 0.29 |
| Debt / assetsi | 1,476.31 | 1,147.14 | 164.05 | 44.39 | 25.71 | 18.64 |
| LT debt / equityi | -- | -- | -- | -- | 20.63 | 10.89 |
| Interest coveragei | -5.40 | -4.53 | -15.35 | -21.48 | -32.97 | -18.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
United Kingdom and Europe49.88%
North America42.42%
Asia Pacific7.70%
Quote time 2026-10-08 09:20:03 · For reference only, not investment advice and not tailored to your situation.